Published on 29 May 2026, this report covers the completed 28 May 2026 market day. It reviews the Sigloid Index, Bitcoin, Gold, intraday breakouts and breakdowns, confirmed daily moves, and linked asset pages for deeper coin-level analysis.
Sigloid Index: SIDEWAYS |Bitcoin: SIDEWAYS |Gold: BEARISH
Confirmed: 43 crypto breakdowns, 3 crypto breakouts, 0 TradeFi breakdowns, 1 TradeFi breakout.
Intraday: 51 support tests and 1 resistance tests before the daily close.
Bitcoin (BTC) closed at 73,591.4 USDT on May 28, 2026, down 1.11%. It remains sideways inside its 55-day range. BTC is trading below short-term moving averages while still holding above longer-term support. MA9 at 76,172.4 USDT may cap short-term recovery attempts, while MA100 at 72,949.06 USDT remains the more significant structural support area. Open interest changed only +0.02% in one day and remains near the lower side of its 30-day range. View detailed Bitcoin analysis
Gold closed at 4,497.85 USDT on May 28, 2026, up 1.08%. It remains in a bearish structure. MA9 at 4,526 USDT stands as the first moving-average resistance area to reclaim. Open interest increased +7.38% in one day and moved above its 30-day range. View detailed Gold analysis
Sigloid Index measures the broader crypto market bias. Sigloid Index closed at 781.80 with SIDEWAYS structure while the primary regime remains BEARISH. The index level sits in the lower half of its 55-day market range, with support near 742.84 and resistance near 908.78. The 14-day average stands at 811.02, so the index still needs a cleaner close above or below its key range levels before the broader backdrop turns decisive. Read more about the Sigloid Index
On the closed daily candle, 47 assets confirmed new structure changes: 4 closed above resistance and 43 closed below support. Crypto drove most of the move, with 3 upside closes and 43 downside closes; tokenized TradeFi added 1 upside close and 0 downside closes. The day leaned defensive, but the Sigloid Index stayed sideways, so this was asset-level weakness rather than a confirmed market-wide breakdown.
No events in this category today.
Intraday activity showed 52 support and resistance events: 1 resistance test and 51 support tests across Sigloid’s tracked market universe. Crypto accounted for 1 resistance test and 49 support tests; tokenized TradeFi accounted for 0 resistance tests and 2 support tests. The live tape leaned defensive before the daily close.
No events in this category today.
This section groups today’s breakout and breakdown assets by how closely they move with the Sigloid Index. Classification uses the latest 30-day correlation, beta, and R² readings.
Confirmed Breakdowns
Intraday Support Tests
Confirmed Breakdowns
Intraday Support Tests
Intraday Resistance Tests
Confirmed Breakdowns
Intraday Support Tests
Confirmed Breakouts
This section groups today’s breakout and breakdown assets by how closely they move with Bitcoin. Classification uses the latest 30-day correlation, beta, and R² readings.
Confirmed Breakdowns
Intraday Support Tests
Intraday Resistance Tests
Confirmed Breakdowns
Confirmed Breakdowns
Intraday Support Tests
Confirmed Breakouts
The main change was broader downside pressure. Today, 43 assets closed below support, up from 31 in the previous report, while assets closing above resistance stayed at 4. Crypto accounted for 43 of today’s downside closes; tokenized TradeFi recorded none. Intraday support tests rose from 16 to 51 assets: 49 crypto assets and 2 tokenized TradeFi assets tested support before the daily close. The Sigloid Index stayed SIDEWAYS, Bitcoin stayed SIDEWAYS, and Gold stayed BEARISH, so weakness broadened below the surface but did not confirm a market-wide breakdown.
The market weakened under the surface: 43 assets closed below support versus 4 above resistance. The confirmed downside pressure came from crypto, with 43 crypto assets closing below support. Within tokenized TradeFi, intraday weakness came from 2 commodities. The Sigloid Index remains SIDEWAYS, so this is broad asset-level pressure rather than a confirmed market-wide breakdown.